Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
1994-12-02
2001-07-24
Ungar, Susan (Department: 1642)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S023500, C435S069100, C435S070100, C435S173300, C435S173300, C435S320100
Reexamination Certificate
active
06265556
ABSTRACT:
FIELD OF THE INVENTION
This invention relates generally to the fields of molecular biology and molecular medicine and more specifically to proteins involved in the regulation of immunological responses and cell growth
BACKGROUND INFORMATION
Immunological responses can be broadly classified as humoral and cell-mediated. Humoral responses are mediated by antibody molecules present in plasma, lymph or tissue fluids and produced by plasma cells that differentiate from immature B cells. An antibody has both recognition and effector function that plays a key role in eliminating bacteria, neutralizing viruses and in triggering degranulation of mast cells and basophils. Cell-mediated immune responses are those mediated by antigen-specific T cells and various nonspecific cells of the immune system, such as natural killer cells, phagocytic cells and other white blood cells. Cell-mediated responses protect against infections due to intracellular bacteria, viruses or yeasts.
Despite the separate classifications of immunological responses, the humoral immune response is highly dependent for its function on a class of T cells known as T helper cells (T
H
cells). Antigens that require T
H
cells to elicit a humoral immune response are known as T-dependent antigens. During the humoral response to T-dependent antigens, T
H
cells make direct contact with B cells, which results in B cell proliferation and immunoglobulin (Ig) class switching from the IgM class to IgG, IgA or IgE antibody classes. Various receptor-ligand interactions are involved in mediating contact between a T
H
cell and a B cell during the response to a T-dependent antigen. In particular, CD40—CD40 ligand (CD40L) pairing is critical to achieving this cell-cell interaction.
CD40L and CD40 are both transmembrane glycoproteins that are homologous to tumor necrosis factor (TNF) and TNF receptors, (TNF-R), respectively. CD40 has a role in a variety of B cell functions, such as inducing Ig class-switching, acting as a cofactor with specific antigen and certain lymphokines for B cell mitogenesis, providing signals that prevent apoptotic cell death and triggering B cell adhesion to other cells. CD40L is not expressed on resting T
H
cells but can be induced after the cell contacts specific antigen.
The function of CD40/CD40L interactions in the immune response is revealed by hereditary abnormalities of CD40L, which cause an X-linked immunodeficiency syndrome. This syndrome is characterized by hyper-production of IgM, reduced levels of IgG, failure to produce IgA and IgE and absence of germinal centers in lymphoid tissues. The germinal centers are structures associated with T-dependent antibody responses. Nearly identical abnormalities are seen in transgenic mice that do not express CD40. These results indicate that the CD40/CD40L interaction provides a non-redundant pathway required for achieving T-dependent antibody responses in vivo.
It currently is unclear how CD40 transduces its CD40L-binding signal into a B cell. Since CD40 is present on the cell surface, its action likely is mediated by CD40 binding to one or more intracellular proteins, which ultimately effect signal transduction pathways that control Ig class-switching, cell proliferation and cell survival. However, the cytoplasmic domain of CD40 provides no clues as to how intracellular signalling is accomplished since the domain lacks homology to kinases or other enzymes known for mediating intracellular signalling.
The identification of intracellular proteins that can associate with CD40 and transduce the CD40L-binding signal into a cell would provide a means to manipulate various cellular functions, including, for example, humoral immune responses and apoptosis. Thus, a need exists to identify proteins that associate with CD40. The present invention satisfies this need and provides additional advantages as well.
SUMMARY OF THE INVENTION
The present invention provides substantially purified mammalian CD40-associated protein (CAP), which is related to the TRAF family of signal transducing proteins. The invention also provides nucleic acid molecules encoding CAPs, vectors containing the nucleic acid molecules and host cells containing the vectors. For example, the invention provides a substantially purified human CAP-1 and a nucleic acid molecule encoding human CAP-1. The invention also provides antibodies that can specifically bind to a CAP.
The present invention also provides a screening assay useful for identifying agents that can effectively alter the association of a CAP with a second molecule that binds to the CAP in a cell. By altering the association of a CAP with a second molecule, an effective agent can increase or decrease the level of apoptosis in a cell.
The invention further provides methods of identifying a CAP agonist or CAP antagonist that can increase or decrease, respectively, the level of expression of the CAP in a cell and thereby modulate a function of the cell.
The invention also provides methods of detecting a CAP in a sample by detecting the presence of the CAP protein or of a nucleic acid molecule encoding the CAP. Such methods can be used to diagnose a pathology that is characterized by an increased or decreased level of expression of a CAP in a cell.
REFERENCES:
Armitage et al., “Molecular and biological characterization of a murine ligand for CD40”Nature357:80-82 (1992).
Choi et al., “Inducton of NF-AT in normal B lymphocytes by anti-immunoglobulin or CD40 ligand in conjunction with IL-4.”Immunity1:179-187 (1994).
Foy et al., “In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39.”J. Exp. Med.178:1567-1575 (1993).
Freemont, P.S. The Ring finger. A novel protein sequence motif related to the Zinc finger. In:Annals New York Academy of Sciences 174-192 (1993).
Gascan et al., “Anti-CD40 monoclonal antibodies of CD4+ T cell clones and IL-4 induce IgG4 and IgE switching in purified human B cells via different signaling pathways.”J. Immunol.147:8-13 (1991).
Itoh and Nagata, “A novel protein domain required for apoptosis.”J. Biol. Chem.268:10932-10937 (1993).
Itoh et al., “The polpeptide encoded by the cDNA for human cell surface antigen fas can mediate apoptosis.”Cell66:233-243 (1991).
Hollenbaugh et al., “The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the C40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity.”EMBO J.11:4313-4321 (1992).
Kawabe et al., “The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation.”Immunity1:167-178 (1994).
Knox and Gordon, “Protein tyrosine phosphorylation is mandatory for CD40-mediated rescue of germinal center B cells from apoptosis.”Eur. J. Immunology23:2578-2584 (1993).
Liu et al., “Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis.”Eur. J. Immunol.21:1905-1910 (1991).
Lovering et al., “Identification and preliminary characterization of a protein motif related to the zinc finger.”Proc. Natl. Acad. Sci. USA90:2112-2116 (1993).
Loetscher et al., “Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor.”Cell61:351-359 (1990).
Noelle et al., “CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation.”Immunol. Today13:431-433 (1992).
Noelle et al., “A39-dKa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells.”Proc. Natl. Acad. Sci. USA89:6550-6554 (1992).
Oehm et al., “Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor
erve growth factor receptor superfamily.”J. Biol. Chem.267:10709-10715 (1992).
Paulie et al., “A p50 surface antigen restricted to human urinary bladder carcinomas an B lymphocytes.”Cancer Immunol. Immunother.20:23-28 (1985).
Paulie et al., “The human B lymphocyte and carcinoma antigen, CDw40, is a phosphoprotein inv
Reed John C.
Sato Takaaki
Campbell & Flores LLP
The Burnham Institute
Ungar Susan
LandOfFree
Nucleic acid encoding CD40 associated proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleic acid encoding CD40 associated proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acid encoding CD40 associated proteins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2438607